|Generic Name||Brand Name|
Gemcitabine is an intravenous (IV) medicine that is usually given in a dose based on body surface area. The type and extent of a cancer determines the exact dose and schedule of administering this drug.
It's usually given through a needle in a vein. Each dose takes about 30 minutes. Doses may be repeated weekly, depending on treatment needs.
Gemcitabine interferes with how cells divide, which stops the growth of the cancer cells. It is used to treat pancreatic and lung cancer. It may also be used to treat bladder, breast, ovarian, or cervical cancer or lymphoma.
Gemcitabine is effective against many forms of cancer. But the type and extent of a cancer determines how effectively this medicine slows or stops the growth of cancer cells in the body.
Possible serious side effects of gemcitabine include:
Less serious side effects are more common and may include:
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
Gemcitabine should be administered only under the supervision of a medical oncologist.
You may not be able to become pregnant or father a child after taking this medicine. Discuss fertility with your doctor before starting treatment.
Gemcitabine can cause birth defects. Do not use this medicine if you are pregnant or wish to become pregnant or to father a child while you are taking it.
Do not breast-feed while you are using gemcitabine.
Do not use this medicine if you have:
Other Works Consulted
- Abramowicz M (2003). Treatment guidelines: Drugs of choice for cancer. Medical Letter on Drugs and Therapeutics, 1(7): 41–52.
To learn more visit Healthwise.org
© 1995-2013 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.